Melinda A Miller
Overview
Explore the profile of Melinda A Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crowder R, Phommaly C, Tao Y, Hoog J, Luo J, Perou C, et al.
Cancer Res
. 2009 Apr;
69(9):3955-62.
PMID: 19366795
Several phosphoinositide 3-kinase (PI3K) catalytic subunit inhibitors are currently in clinical trial. We therefore sought to examine relationships between pharmacologic inhibition and somatic mutations in PI3K catalytic subunits in estrogen...
2.
FitzGerald L, Agalliu I, Johnson K, Miller M, Kwon E, Hurtado-Coll A, et al.
BMC Cancer
. 2008 Aug;
8:230.
PMID: 18694509
Background: The presence of the TMPRSS2-ERG fusion gene in prostate tumors has recently been associated with an aggressive phenotype, as well as recurrence and death from prostate cancer. These associations...
3.
Press J, Kenyon J, Xue H, Miller M, De Luca A, Miller D, et al.
Gynecol Oncol
. 2008 Jun;
110(2):256-64.
PMID: 18547621
Objectives: Human cancer tissue xenograft models may provide a more accurate reflection of tumor biology than cell lines. This study evaluates the genetic and phenotypic stability of primary human gynecological...
4.
Brown L, Kalloger S, Miller M, Shih I, McKinney S, Santos J, et al.
Genes Chromosomes Cancer
. 2008 Mar;
47(6):481-9.
PMID: 18314909
Amplification at the 11q13 locus is commonly observed in breast, ovarian, head and neck, oral, and esophageal cancer. Studies of this region led to the identification of multiple amplicons containing...
5.
Guan Y, Kuo W, Stilwell J, Takano H, Lapuk A, Fridlyand J, et al.
Clin Cancer Res
. 2007 Oct;
13(19):5745-55.
PMID: 17908964
Purpose: This study was designed to elucidate the role of amplification at 8q24 in the pathophysiology of ovarian and breast cancer because increased copy number at this locus is one...
6.
Cupp J, Miller M, Montgomery K, Nielsen T, OConnell J, Huntsman D, et al.
Am J Surg Pathol
. 2007 May;
31(6):970-6.
PMID: 17527089
We recently demonstrated that CSF1, the ligand of the tyrosine kinase receptor, CSF1R, can be translocated in pigmented villonodular synovitis (PVNS) and tenosynovial giant cell tumor (TGCT). In this study,...
7.
Lapointe J, Kim Y, Miller M, Li C, Kaygusuz G, van de Rijn M, et al.
Mod Pathol
. 2007 Mar;
20(4):467-73.
PMID: 17334351
Prostate cancer is the most commonly diagnosed cancer among men in the United States. Recently, fusion of TMPRSS2 with ETS family oncogenic transcription factors has been identified as a common...
8.
Rajput A, Miller M, De Luca A, Boyd N, Leung S, Hurtado-Coll A, et al.
J Clin Pathol
. 2007 Jan;
60(11):1238-43.
PMID: 17259299
Background: Recent reports indicate that prostate cancers (CaP) frequently over-express the potential oncogenes, ERG or ETV1. Many cases have chromosomal rearrangements leading to the fusion of the 5' end of...
9.
West R, Rubin B, Miller M, Subramanian S, Kaygusuz G, Montgomery K, et al.
Proc Natl Acad Sci U S A
. 2006 Jan;
103(3):690-5.
PMID: 16407111
Tenosynovial giant-cell tumor (TGCT) and pigmented villonodular synovitis (PVNS) are related conditions with features of both reactive inflammatory disorders and clonal neoplastic proliferations. Chromosomal translocations involving chromosome 1p13 have been...
10.
Prentice L, Shadeo A, Lestou V, Miller M, deLeeuw R, Makretsov N, et al.
Oncogene
. 2005 Jul;
24(49):7281-9.
PMID: 16027731
Rearrangements of the neuregulin (NRG1) gene have been implicated in breast carcinoma oncogenesis. To determine the frequency and clinical significance of NRG1 aberrations in clinical breast tumors, a breast cancer...